These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25629421)

  • 1. High iron content of Ankaferd hemostat as a clue for its hemostatic action of red blood cell origin.
    Akar N; Ardçoğlu Y; Öktem Z; Erduran N; Haznedaroglu IC
    Blood Coagul Fibrinolysis; 2015 Mar; 26(2):233-4. PubMed ID: 25629421
    [No Abstract]   [Full Text] [Related]  

  • 2. Microvascular anastomosis using Ankaferd blood stopper: demonstration of long-term histopathologic effects on vascular tissue.
    Saçak B; Akdeniz ZD; Şirinoğlu H; Çilingir ÖT; Çelebiler ÖB; Ercan F; Numanoğlu A
    Blood Coagul Fibrinolysis; 2014 Oct; 25(7):721-5. PubMed ID: 24806319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Antithrombin Effect of Ankaferd Hemostat (ABS) Is Related to the High Iron Content of the Medicine.
    Okay M; Ozturk Y; Haznedaroglu IC
    Clin Appl Thromb Hemost; 2019; 25():1076029618824416. PubMed ID: 30808215
    [No Abstract]   [Full Text] [Related]  

  • 4. Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat.
    Haznedaroglu BZ; Beyazit Y; Walker SL; Haznedaroglu IC
    Crit Rev Oncol Hematol; 2012 Jul; 83(1):21-34. PubMed ID: 22079213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trace element & vitamin content of Ankaferd hemostat and hepatoprotective effect.
    Güneş B; Ardıçoğlu Akışın NY; Akar N
    Turk J Med Sci; 2021 Dec; 51(6):3136-3137. PubMed ID: 34773687
    [No Abstract]   [Full Text] [Related]  

  • 6. Ankaferd hemostat: from molecules to medicine.
    Çiftçiler R; Haznedaroglu İC
    Turk J Med Sci; 2020 Nov; 50(SI-2):1739-1750. PubMed ID: 32283900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of the hemostatic agent Ankaferd blood stopper on end-to-end unilateral sleeve fish-mouth anastomosis.
    Karasoy Yeşilada A; Bayraktaroğlu SB; Sevim KZ; Sakız D; Tatlıdede HS
    Acta Orthop Traumatol Turc; 2014; 48(1):92-7. PubMed ID: 24643107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper.
    Haznedaroglu BZ; Haznedaroglu IC; Walker SL; Bilgili H; Goker H; Kosar A; Aktas A; Captug O; Kurt M; Ozdemir O; Kirazli S; Firat HC
    Clin Appl Thromb Hemost; 2010 Aug; 16(4):446-53. PubMed ID: 19833624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper.
    Aydin S
    J Int Med Res; 2009; 37(1):279. PubMed ID: 19215704
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of hemostatic effects of Ankaferd as an alternative medicine.
    Beyazit Y; Kurt M; Kekilli M; Goker H; Haznedaroglu IC
    Altern Med Rev; 2010 Dec; 15(4):329-36. PubMed ID: 21194248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 2008; 36:163-170.
    Uçar Albayrak C; Calişkan U; Haznedaroglu IC; Goker H
    J Int Med Res; 2008; 36(6):1447-8; author reply 1448-9. PubMed ID: 19094458
    [No Abstract]   [Full Text] [Related]  

  • 12. Effective management of hemoptysis via endobronchial application of Ankaferd hemostat.
    Uzun O; Erkan L; Haznedaroglu IC
    Arch Bronconeumol; 2014 Sep; 50(9):407-9. PubMed ID: 24491888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model.
    Kosar A; Cipil HS; Kaya A; Uz B; Haznedaroglu IC; Goker H; Ozdemir O; Ercetin S; Kirazli S; Firat HC
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):185-90. PubMed ID: 19657315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the Antiproliferative Effect of Ankaferd Hemostat on Caco-2 Colon Cancer Cells via LC/MS Shotgun Proteomics Approach.
    Koçak E; Çelebier M; Haznedaroglu IC; Altınöz S
    Biomed Res Int; 2019; 2019():5268031. PubMed ID: 31240215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ankaferd hemostat for the management of tumoral GI bleeding.
    Beyazit Y; Kekilli M; Kurt M; Sayilir A; Haznedaroglu IC
    Gastrointest Endosc; 2011 May; 73(5):1072-3. PubMed ID: 21521581
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucosal trauma induced apoptosis in guinea pig middle ear: comparision of hemostatic agents.
    Eren E; Başoğlu MS; Kulduk E; Şimsek F; İnan S
    Int J Pediatr Otorhinolaryngol; 2014 Dec; 78(12):2222-8. PubMed ID: 25458164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Ankaferd hemostat application for the management of oral cavity bleedings in children with hemorrhagic diathesis.
    Leblebisatan G; Bay A; Karakus SC; Kekilli M; Haznedaroglu IC
    Blood Coagul Fibrinolysis; 2012 Sep; 23(6):494-7. PubMed ID: 22576286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prohemostatic and antithrombin activities of Ankaferd hemostat are linked to fibrinogen gamma chain and prothrombin by functional proteomic analyses.
    Ozel-Demiralp D; Igci N; Ayhan B; Egin Y; Haznedaroglu IC; Akar N
    Clin Appl Thromb Hemost; 2012 Nov; 18(6):604-10. PubMed ID: 22327821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines.
    Turk S; Malkan UY; Ghasemi M; Hocaoglu H; Mutlu D; Gunes G; Aksu S; Haznedaroglu IC
    SAGE Open Med; 2017; 5():2050312116689519. PubMed ID: 28293423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hemostatic agents on fibroblast cells.
    Emes Y; Aybar B; Vural P; Işsever H; Yalçn S; Atalay B; Dinçol E; Bilir A
    Implant Dent; 2014 Dec; 23(6):641-7. PubMed ID: 25343319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.